About Adwia Pharmaceuticals
Adwia Pharmaceuticals is a Healthcare company based in Cairo (Egypt) founded in 1984, and was acquired by EBRD in November 2020. Drugs for human and veterinary diseases are developed. Adwia Pharmaceuticals offers products and services including Generic Medicines and Animal Health Products. Its focus areas include Diversified Pharmaceuticals.
Company details
Developer of drugs for treating multiple diseases. The companys proprietary platform aims to develop human and veterinary medications for multiple health disorders. It has developed Adwiprill tablets for treating antihypertensives cardiovascular diseases. It also offers myogrel tablets for antiplatelets, intranox capsules, dinar antibiotics for treating infectious diseases, bronchofreee capsules for respiratory systems, inocont tablets for urinary tract infections, nopecia for dermatology, tibolone tablets for gynecology treatments. The platform also provides veterinary medicines such as antibiotics chemotherapeutics, analgesics, anthelmintics, anti-coccidiosis anti-protozoal, antifungals, and many more.
Products & Services of Adwia Pharmaceuticals
Adwia Pharmaceuticals offers a comprehensive portfolio of products and services, including Generic Medicines and Animal Health Products.
Provides generic drugs for human health in various therapeutic categories
Offers medicines for animal health and infection control needs
Investors in Adwia Pharmaceuticals
Adwia Pharmaceuticals has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include EBRD, British International Investment and DPI.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Corporate advisory services are provided across multiple sectors. | 1991 | ebrd.com | London, United Kingdom | |
Government agency focused on small and medium-sized businesses | 1948 | bii.co.uk | London, United Kingdom | |
A premier African investment firm focused on high-growth businesses. | 2007 | dpi-llp.com | London, United Kingdom |
Investor details for Adwia Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Adwia Pharmaceuticals
8 people are tracked at Adwia Pharmaceuticals (5 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Hossam Taher | CEO and co-founder | Leadership |
Mohamed Bedeer | Animal Health Business Unit Head | Leadership |
Fouad Hanna | Head Of Training And Development | Leadership |
Mohamed Sultan | Sales Director | Leadership |
Salama Hemida | TOLL Manufacturing Section HEAD | Leadership |
Karim Seif | Regional Sales Manager | Team |
Ahmed Yasser | Talent Acquisition & Training Supervisor | Team |
Dr. Hany Khairy | Medical And Pharmacovigilance Manager | Team |
Complete people profiles for Adwia Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Adwia Pharmaceuticals
2 dated milestones of Adwia Pharmaceuticals across 36 years, from founding to its latest funding, stage changes and deals.
- Founded Adwia Pharmaceuticals is founded.
- Exit Acquired by EBRD.
Web traffic of Adwia Pharmaceuticals
The website of Adwia Pharmaceuticals (adwia.com) receives about 3.9K visits a month and ranks #2,648,378 among all websites worldwide, #3,384 in Pharmacy.
- Monthly visits3.9K
▼ 29.1% vs previous month
- Unique visitors1.8K
per month
- Global rank#2,648,378
among all websites
- Category rank#3,384
Health · Pharmacy
- Bounce rate27%
- Pages per visit3.8
- Average visit2 min 31 sec
- DevicesDesktop 48% · Mobile 52%
Websites whose visitors overlap most with Adwia Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| globalnapi.com | 100% | 680.7K | View details | ||
| evapharma.com | 100% | 108.3K | #262,461 | View details | |
| nerhadou.com | 97% | 1.4K | #886,702 | View details | |
| vitanepharma.com | 83% | #4,166,982 | View details | ||
utopiapharma.com | utopiapharma.com | 81% | #3,117,260 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for Adwia Pharmaceuticals
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Adwia Pharmaceuticals
Complete news archive for Adwia Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Adwia Pharmaceuticals
Adwia Pharmaceuticals was founded in 1984.
Adwia Pharmaceuticals is headquartered in Cairo, Egypt.
Developer of drugs for treating multiple diseases. The companys proprietary platform aims to develop human and veterinary medications for multiple health disorders. It has developed Adwiprill tablets for treating antihypertensives cardiovascular diseases. It also offers myogrel tablets for antiplatelets, intranox capsules, dinar antibiotics for treating infectious diseases, bronchofreee capsules for respiratory systems, inocont tablets for urinary tract infections, nopecia for dermatology, tibolone tablets for gynecology treatments. The platform also provides veterinary medicines such as antibiotics chemotherapeutics, analgesics, anthelmintics, anti-coccidiosis anti-protozoal, antifungals, and many more.
Adwia Pharmaceuticals offers Generic Medicines and Animal Health Products.
Adwia Pharmaceuticals has 3 investors. Key investors include EBRD, British International Investment, and DPI.
Yes. Adwia Pharmaceuticals was acquired by EBRD in November 2020.